CD3-CD16+ (NK) cells are rapidly and markedly affected by interferon β 1b (INFβ1b) therapy in relapsing-remitting MS patients

1998 
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []